Immediate Impact

3 hit
Sub-graph 1 of 2

Citing Papers

Challenges in the practical implementation of blood biomarkers for Alzheimer’s disease
2024 Hit
Guillain-Barré syndrome
2021 Hit

Works of Kenta Noda being referenced

Cost-effectiveness comparison between blood biomarkers and conventional tests in Alzheimer's disease diagnosis
2024
Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndrome
2014
Rankless by CCL
2026